Cancer care has advanced at an impressive pace and improved the lives of millions. Now, emerging technologies promise ever-more-powerful capabilities in how we prevent, diagnose and treat cancer. Might we one day defeat this disease entirely? Listen as our guests Dr. Aleksandra Rizo, Head of R&D at Vividion Therapeutics, and Prof. Dr. Dominik Rüttinger, Head of Research & Early Development Oncology at Bayer, explore the most promising breakthroughs and discuss the challenges they face and what keeps them going.